TMT Newswire > GlobeNewswire
ARC Fertility and Sapyen Announce Strategic Partnership to Revolutionize Male Fertility Testing, Expanding Reproductive Health Benefits for Employers and Workforces

CUPERTINO, Calif. and MELBOURNE, Australia, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, is proud to announce a strategic partnership with Sapyen, a global innovator in at-home male fertility testing. This collaboration provides opportunities for employers to offer their male employees and health plan members a seamless fertility testing experience from the comfort and privacy of their homes, a significant benefit as 1 in 6 couples faces difficulties in conceiving, 50% of all fertility issues are male-related and many studies show there has been a significant decline in sperm count globally over the last fifty years,

'Our partnership with Sapyen aligns perfectly with our mission to deliver high-quality, cost-effective and flexible family-forming and fertility benefits that enhance employee satisfaction and loyalty while contributing to improved health outcomes and cost savings,” says David Adamson, MD, founder and CEO, ARC Fertility. 'By offering the Sapyen at-home fertility test, we are providing a unique, accessible and discreet option for male fertility testing that will significantly benefit our clients and their employees. The Sapyen solution is crucial in addressing reproductive challenges early on to minimize costs and provide more opportunities to explore options on the path to parenthood.”

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here